Image Not Found
Investment Growth with Portfolio Balance and Risk Management
info@merciafund.co.uk

Molecular Solar

logo-molecular

Molecular Solar is a spin-out company from the University of Warwick. The Company has been established to commercialise third generation solar cell technology developed in a multi-million pound R&D programme at the University.

Click here to return to Portfolio Companies
Sarissa Biomedical is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines and other neurochemicals, as indicators of neurological activity/disorders. Circadian Solar is a leading developer of concentrated photovoltaic technology, a form of solar power that unlocks the potential of the sun to deliver clean, renewable and affordable energy. Celentyx Ltd is a pharmaceutical research and development company that uses a novel technology called Novel Clinical Identification Profiling™ to assess the suitability of existing drugs in the treatment of new illnesses. Allinea Software specialises in developing software tools designed to ensure that applications can run problem-free on parallel computing systems. LM Technologies are developing innovative wireless products including the world’s smallest Bluetooth adapter. Intelligent Orthopaedics specialises in the design and development of products for treating orthopaedic trauma. nanoTheric's patented technology uses nanoparticles and magnetic fields to facilitate the delivery of molecules such as DNA into living cells. Nightingale EOS has developed laser-based technology called Beam Profile Reflectometry which is able to measure the characteristics of the thin coatings applied to medical implants such as cardiac stents and replacement joints. Anaxsys is a cutting edge sensor technology company that is developing a range of respiratory diagnostic and monitoring products based upon their unique sensor technology. Warwick Audio Technologies has developed a radically new type of mid-range loudspeaker that is ultra-thin, lightweight, flexible and inexpensive to manufacture.

  • Latest News

  • Search

  • Sign up for our mailing list.

  • Follow us on LinkedIn

    • Mecia Fund Managament Ltd (registered in England No. 06973399) is authorised and regulated by the Financial Conduct Authority in the conduct of its Investment Business